Alluvi Retatrutide 40mg — Research-Grade Triple Agonist Pre-Filled Pen

Alluvi Retatrutide 40mg offers a comprehensive research formulation of the novel multi-target peptide Retatrutide, supplied as a pre-filled delivery system configured for 4 individual doses of 10mg each. As an investigational triple hormone receptor agonist, Retatrutide simultaneously engages three distinct metabolic signaling pathways:

• GLP-1 Receptors: Glucagon-like peptide-1 pathway activity and downstream intracellular signaling cascades.

• GIP Receptors: Glucose-dependent insulinotropic polypeptide receptor mechanisms and complementary metabolic kinetics.

• Glucagon Receptors: Glucagon pathway binding, energy substrate regulation, and lipid metabolism interactions.

This concurrent engagement across three key metabolic axes provides researchers with a robust, versatile tool to investigate receptor cross-talk, synergistic signaling mechanisms, and peptide dynamics within a single standardized compound.

Key Specifications & Presentation

Target Laboratory & Scientific Applications

• Comparative evaluation of triple-receptor agonism versus single- or dual-agonist peptides.

• In-vitro receptor binding kinetics, affinity assays, and intracellular signal transduction studies.

• Exploration of metabolic pathway cross-talk, lipid regulation, and glucose-dependent signaling mechanisms.

• Peptide formulation stability, degradation rates, and solubility profiling under controlled conditions.

Storage & Handling Protocols

• Refrigeration: Store immediately upon receipt in a laboratory refrigerator at 2°C to 8°C.

• Environmental Protection: Protect the pre-filled device from exposure to direct sunlight, excessive heat, and freezing temperatures.

• Traceability: Maintain batch codes, packaging seals, and analytical documentation alongside institutional laboratory records.

• Laboratory Safety: Handle strictly according to institutional chemical hygiene plans and standard synthetic peptide handling protocols.

Regulatory Notice & Intended Use

Strictly for Research Use Only (RUO): Alluvi Retatrutide 40mg is supplied exclusively for non-clinical laboratory research, in-vitro scientific study, and analytical evaluation. It is not an approved medicine, therapeutic agent, food product, or cosmetic, and is strictly prohibited for human or veterinary administration, medical treatment, diagnosis, or clinical use.